Literature DB >> 17474131

Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates.

Lili Wang1, Fatima Abbasi, Adolfas K Gaigalas, Robert A Hoffman, Dan Flagler, G E Marti.   

Abstract

BACKGROUND: Numerous methods for quantitative fluorescence calibration (QFC) have been developed to quantify receptor expression on lymphocytes. However, the results from the use of these different QFC methods vary considerably in the literature. To better identify the causes of these discrepancies, we measured CD4 expression using FITC and phycoerythrin (PE) conjugates to stain CYTO-TROL Control Cells and T-lymphocytes in whole blood and isolated cell preparations. We further examined pH of the cellular microenvironment as a cause of discordant results obtained with the FITC conjugate.
METHODS: Calibration with Quantibrite PE-labeled microspheres and the use of unimolar CD4-PE conjugates provided direct measurement of the antibody bound per cell value (ABC) for CD4 expression on normal T-lymphocytes. Calibration for CD4-FITC monoclonal antibody (Mab) labeled CYTO-TROL Control Cells and normal T-lymphocytes was based on molecules of equivalent soluble fluorochrome (MESF) as determined by FITC-labeled microspheres traceable to NIST RM 8640. The MESF value for CD4-FITC Mab was determined that enabled the conversion of the MESF values obtained for CYTO-TROL cells to ABC. We investigated the likely pH change in the fluorescein microenvironments within FITC-labeled Mab and cells stained with FITC-labeled Mab using a pH sensitive indicator.
RESULTS: The mean ABC value for T-lymphocytes prepared from fresh whole blood using CD4-PE conjugate (48,321) was consistent with previous results, and it was much higher than the mean ABC using CD4-FITC Mab (22,156). The mean ABC value for CYTO-TROL cells using CD4-PE conjugate (43,090) was also higher than that using CD4-FITC conjugate (34,734), although the discrepancy was not as great. Further studies suggested the discrepancy in CYTO-TROL results may be accounted for by the low pH of the membrane microenvironment, but the greater discrepancy in T-lymphocytes could not be fully explained.
CONCLUSION: CD4 expression on fresh normal whole blood samples and CYTO-TROL cells can be consistently quantified in ABC units using Quantibrite PE quantification beads and unimolar CD4-PE conjugates. Quantification with CD4-FITC conjugate is not as consistent, but may be improved by the use of CD4 T-cells as biological calibrators. This approximation is valid only for surface receptors with consensus ABC values measured by different QFC methods serving as biological standards.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17474131     DOI: 10.1002/cyto.b.20354

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  9 in total

1.  Variables affecting the quantitation of CD22 in neoplastic B cells.

Authors:  Gregory A Jasper; Indu Arun; David Venzon; Robert J Kreitman; Alan S Wayne; Constance M Yuan; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-09-24       Impact factor: 3.058

2.  Improved reproducibility by assuring confidence in measurements in biomedical research.

Authors:  Anne L Plant; Laurie E Locascio; Willie E May; Patrick D Gallagher
Journal:  Nat Methods       Date:  2014-09       Impact factor: 28.547

3.  Variables in the quantification of CD4 in normals and hairy cell leukemia patients.

Authors:  Lili Wang; Fatima Abbasi; Gregory A Jasper; Robert J Kreitman; David J Liewehr; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2011-01       Impact factor: 3.058

4.  Characterization and Quantification of Nanoparticle-Antibody Conjugates on Cells Using C(60) ToF SIMS in the Event-By-Event Bombardment/Detection Mode.

Authors:  Li-Jung Chen; Sunny S Shah; Jaime Silangcruz; Michael J Eller; Stanislav V Verkhoturov; Alexander Revzin; Emile A Schweikert
Journal:  Int J Mass Spectrom       Date:  2011-06-01       Impact factor: 1.986

5.  Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.

Authors:  Alison M Betts; Nahor Haddish-Berhane; John Tolsma; Paul Jasper; Lindsay E King; Yongliang Sun; Subramanyam Chakrapani; Boris Shor; Joseph Boni; Theodore R Johnson
Journal:  AAPS J       Date:  2016-05-19       Impact factor: 4.009

6.  Identification of non-activated lymphocytes using three-dimensional refractive index tomography and machine learning.

Authors:  Jonghee Yoon; YoungJu Jo; Min-Hyeok Kim; Kyoohyun Kim; SangYun Lee; Suk-Jo Kang; YongKeun Park
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

7.  High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry.

Authors:  Carmen Campos-Silva; Henar Suárez; Ricardo Jara-Acevedo; Estefanía Linares-Espinós; Luis Martinez-Piñeiro; María Yáñez-Mó; Mar Valés-Gómez
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

8.  CD Maps-Dynamic Profiling of CD1-CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets.

Authors:  Tomas Kalina; Karel Fišer; Martin Pérez-Andrés; Daniela Kuzílková; Marta Cuenca; Sophinus J W Bartol; Elena Blanco; Pablo Engel; Menno C van Zelm
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

9.  Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody.

Authors:  Stephen W Jarantow; Barbara S Bushey; Jose R Pardinas; Ken Boakye; Eilyn R Lacy; Renouard Sanders; Manuel A Sepulveda; Sheri L Moores; Mark L Chiu
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.